Recombinant antibody production has emerged as a potent and ground-breaking technology in biomedical research. It has completely transformed the way scientists and researchers study illnesses, create ...

Antibodies are a stalwart tool in biomedical research. Most commonly used are animal-derived polyclonal and monoclonal antibodies (mAbs), and nonanimal-derived recombinant mAbs. According to Simon ...

Antibody production companies are essential in dealing with the growing demand for antibodies for life sciences, therapeutic, and diagnostic applications. Therefore, a number of service providers are ...

In 1975, Georges Köhler and César Milstein, biochemists from the Medical Research Council Laboratory of Molecular Biology, published a paper in Nature about a hybridoma technology that enabled the ...

Key market opportunities for bioprocess automation include the growing demand for biologics, driven by advanced treatments ...

Scientists can circumvent these challenges and keep their research moving forward with Bio X Cell’s in vivo antibodies, which are formulated in preservative-free PBS, tested for pathogens and ...

NEWTON, MA / ACCESS Newswire / January 26, 2026 /Xheme Inc., a biopharmaceutical innovator developing advanced technologies ...

Swedish researchers have developed a microfluidic chip that they hope will allow for easier monitoring of monoclonal antibody (mAb) production. The protein cartridge, developed by a team from KTH ...

Antibodies are Y-shaped protective proteins manufactured by B lymphocytes in reaction to invading pathogens. When B lymphocytes encounter foreign antigens expressed by antigen-presenting cells (e.g.

The monoclonal antibodies in veterinary health market face growth opportunities due to rising animal chronic diseases and pet ...